Global Inflammatory Bowel Disease Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 1163

Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stomach and the anus, whereas ulcerative colitis primarily affects the colon and the rectum.
Medical treatment of IBD is individualised to each patient. The choice of which drugs to use and by which route to administer them (oral, rectal, injection, infusion) depends on factors including the type, distribution, and severity of the patient's disease, as well as other historical and biochemical prognostic factors, and patient preferences. For example, mesalazine is more useful in ulcerative colitis than in Crohn's disease. Generally, depending on the level of severity, IBD may require immunosuppression to control the symptoms, with drugs such as prednisone, TNF inhibitors, azathioprine (Imuran), methotrexate, or 6-mercaptopurine.
In 2018, the global Inflammatory Bowel Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Inflammatory Bowel Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Inflammatory Bowel Disease development in United States, Europe and China.

The key players covered in this study
Bristol-Myers Squibb Company
Baxter International
Johnson & Johnson
Sanofi-Aventis
Abbott Laboratories
Pluristem Therapeutics
Pfizer
AstraZeneca
Cephalon
Amgen

Market segment by Type, the product can be split into
Crohns disease
Ulcerative colitis

Market segment by Application, split into
Therapeutic
Diagnostics

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Inflammatory Bowel Disease status, future forecast, growth opportunity, key market and key players.
To present the Inflammatory Bowel Disease development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Inflammatory Bowel Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Inflammatory Bowel Disease Market Size Growth Rate by Type (2014-2025)
1.4.2 Crohns disease
1.4.3 Ulcerative colitis
1.5 Market by Application
1.5.1 Global Inflammatory Bowel Disease Market Share by Application (2014-2025)
1.5.2 Therapeutic
1.5.3 Diagnostics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Inflammatory Bowel Disease Market Size
2.2 Inflammatory Bowel Disease Growth Trends by Regions
2.2.1 Inflammatory Bowel Disease Market Size by Regions (2014-2025)
2.2.2 Inflammatory Bowel Disease Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Inflammatory Bowel Disease Market Size by Manufacturers
3.1.1 Global Inflammatory Bowel Disease Revenue by Manufacturers (2014-2019)
3.1.2 Global Inflammatory Bowel Disease Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Inflammatory Bowel Disease Market Concentration Ratio (CR5 and HHI)
3.2 Inflammatory Bowel Disease Key Players Head office and Area Served
3.3 Key Players Inflammatory Bowel Disease Product/Solution/Service
3.4 Date of Enter into Inflammatory Bowel Disease Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Inflammatory Bowel Disease Market Size by Type (2014-2019)
4.2 Global Inflammatory Bowel Disease Market Size by Application (2014-2019)

5 United States
5.1 United States Inflammatory Bowel Disease Market Size (2014-2019)
5.2 Inflammatory Bowel Disease Key Players in United States
5.3 United States Inflammatory Bowel Disease Market Size by Type
5.4 United States Inflammatory Bowel Disease Market Size by Application

6 Europe
6.1 Europe Inflammatory Bowel Disease Market Size (2014-2019)
6.2 Inflammatory Bowel Disease Key Players in Europe
6.3 Europe Inflammatory Bowel Disease Market Size by Type
6.4 Europe Inflammatory Bowel Disease Market Size by Application

7 China
7.1 China Inflammatory Bowel Disease Market Size (2014-2019)
7.2 Inflammatory Bowel Disease Key Players in China
7.3 China Inflammatory Bowel Disease Market Size by Type
7.4 China Inflammatory Bowel Disease Market Size by Application

8 Japan
8.1 Japan Inflammatory Bowel Disease Market Size (2014-2019)
8.2 Inflammatory Bowel Disease Key Players in Japan
8.3 Japan Inflammatory Bowel Disease Market Size by Type
8.4 Japan Inflammatory Bowel Disease Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Inflammatory Bowel Disease Market Size (2014-2019)
9.2 Inflammatory Bowel Disease Key Players in Southeast Asia
9.3 Southeast Asia Inflammatory Bowel Disease Market Size by Type
9.4 Southeast Asia Inflammatory Bowel Disease Market Size by Application

10 India
10.1 India Inflammatory Bowel Disease Market Size (2014-2019)
10.2 Inflammatory Bowel Disease Key Players in India
10.3 India Inflammatory Bowel Disease Market Size by Type
10.4 India Inflammatory Bowel Disease Market Size by Application

11 Central & South America
11.1 Central & South America Inflammatory Bowel Disease Market Size (2014-2019)
11.2 Inflammatory Bowel Disease Key Players in Central & South America
11.3 Central & South America Inflammatory Bowel Disease Market Size by Type
11.4 Central & South America Inflammatory Bowel Disease Market Size by Application

12 International Players Profiles
12.1 Bristol-Myers Squibb Company
12.1.1 Bristol-Myers Squibb Company Company Details
12.1.2 Company Description and Business Overview
12.1.3 Inflammatory Bowel Disease Introduction
12.1.4 Bristol-Myers Squibb Company Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.1.5 Bristol-Myers Squibb Company Recent Development
12.2 Baxter International
12.2.1 Baxter International Company Details
12.2.2 Company Description and Business Overview
12.2.3 Inflammatory Bowel Disease Introduction
12.2.4 Baxter International Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.2.5 Baxter International Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Inflammatory Bowel Disease Introduction
12.3.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.3.5 Johnson & Johnson Recent Development
12.4 Sanofi-Aventis
12.4.1 Sanofi-Aventis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Inflammatory Bowel Disease Introduction
12.4.4 Sanofi-Aventis Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.4.5 Sanofi-Aventis Recent Development
12.5 Abbott Laboratories
12.5.1 Abbott Laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 Inflammatory Bowel Disease Introduction
12.5.4 Abbott Laboratories Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.5.5 Abbott Laboratories Recent Development
12.6 Pluristem Therapeutics
12.6.1 Pluristem Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Inflammatory Bowel Disease Introduction
12.6.4 Pluristem Therapeutics Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.6.5 Pluristem Therapeutics Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Inflammatory Bowel Disease Introduction
12.7.4 Pfizer Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.7.5 Pfizer Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Company Details
12.8.2 Company Description and Business Overview
12.8.3 Inflammatory Bowel Disease Introduction
12.8.4 AstraZeneca Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.8.5 AstraZeneca Recent Development
12.9 Cephalon
12.9.1 Cephalon Company Details
12.9.2 Company Description and Business Overview
12.9.3 Inflammatory Bowel Disease Introduction
12.9.4 Cephalon Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.9.5 Cephalon Recent Development
12.10 Amgen
12.10.1 Amgen Company Details
12.10.2 Company Description and Business Overview
12.10.3 Inflammatory Bowel Disease Introduction
12.10.4 Amgen Revenue in Inflammatory Bowel Disease Business (2014-2019)
12.10.5 Amgen Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details